Strong Evidence for a Genetic Contribution to Late-Onset Alzheimer's Disease Mortality: A Population-Based Study

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Kauwe, John S K ^a   Ridge, Perry G ^a   Foster, Norman L ^b   Cannon Albright, Lisa A ^b,c  

^a BRIGHAM YOUNG UNIVERSITY   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; EVIDENCE BASED MEDICINE; FAMILY ASSESSMENT; FAMILY HISTORY; FEMALE; GENE CLUSTER; GENEALOGY; GENETIC ANALYSIS; GENETIC DISTANCE; GENETIC IDENTIFICATION; GENETIC PREDISPOSITION; GENETIC RISK; HERITABILITY; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; ONSET AGE; PEDIGREE ANALYSIS; POPULATION BASED CASE CONTROL STUDY; RISK ASSESSMENT; RISK FACTOR;

ADULT; AGED; ALZHEIMER DISEASE; FEMALE; GENEALOGY AND HERALDRY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PEDIGREE; RISK; UTAH;

EID: 84885117288     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077087     Document Type: Article

References (49)

1. Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, et al. (2011) Alzheimer's disease. Lancet 377: 1019-1031. doi:10.1016/S0140-6736(10)61349-9. PubMed: 21371747.
2. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM, (2007) Forecasting the global burden of Alzheimer's disease. Alzheimers Dement 3: 186-191. doi:10.1016/j.jalz.2007.04.381. PubMed: 19595937.
3. Querfurth HW, LaFerla FM, (2010) Alzheimer's disease. N Engl J Med 362: 329-344. doi:10.1056/NEJMra0909142. PubMed: 20107219.
4. Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, et al. (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349: 704-706. doi:10.1038/349704a0. PubMed: 1671712.
5. Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J, et al. (1995) Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269: 973-977. doi:10.1126/science.7638622. PubMed: 7638622.
6. Lopera F, Ardilla A, Martínez A, Madrigal L, Arango-Viana JC, et al. (1997) Clinical features of early-onset Alzheimer disease in a large kindred with an E280A presenilin-1 mutation. JAMA 277: 793-799. doi:10.1001/jama.277.10.793. PubMed: 9052708.
7. Kauwe JS, Jacquart S, Chakraverty S, Wang J, Mayo K, et al. (2007) Extreme cerebrospinal fluid amyloid beta levels identify family with late-onset Alzheimer's disease presenilin 1 mutation. Ann Neurol 61: 446-453. doi:10.1002/ana.21099. PubMed: 17366635.
8. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, et al. (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923. doi:10.1126/science.8346443. PubMed: 8346443.
9. Naj AC, Jun G, Beecham GW, Wang LS, Vardarajan BN, et al. (2011) Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet 43: 436-441. doi:10.1038/ng.801. PubMed: 21460841.
10. Lambert JC, Heath S, Even G, Campion D, Sleegers K, et al. (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 41: 1094-1099. doi:10.1038/ng.439. PubMed: 19734903.
11. Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, et al. (2011) Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet 43: 429-435. doi:10.1038/ng.803. PubMed: 21460840.
12. Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, et al. (2009) Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet 41: 1088-1093. doi:10.1038/ng.440. PubMed: 19734902.
13. Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, et al. (2012) Variant of TREM2 Associated with the Risk of Alzheimer's Disease. N Engl J Med 368: 107-16. PubMed: 23150908. PubMed: 23150908.
14. Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, et al. (2013) TREM2 variants in Alzheimer's disease. N Engl J Med 368: 117-127. doi:10.1056/NEJMoa1211851. PubMed: 23150934.
15. Pericak-Vance MA, Bebout JL, Gaskell PC Jr, Yamaoka LH, Hung WY, et al. (1991) Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage. Am J Hum Genet 48: 1034-1050. PubMed: 2035524.
16. Schellenberg GD, Bird TD, Wijsman EM, Orr HT, Anderson L, et al. (1992) Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science 258: 668-671. doi:10.1126/science.1411576. PubMed: 1411576.
17. Bergem AL, Engedal K, Kringlen E, (1997) The role of heredity in late-onset Alzheimer disease and vascular dementia. A twin study. Arch Gen Psychiatry 54: 264-270. doi:10.1001/archpsyc.1997.01830150090013. PubMed: 9075467.
18. Gatz M, Svedberg P, Pedersen NL, Mortimer JA, Berg S, et al. (2001) Education and the risk of Alzheimer's disease: findings from the study of dementia in Swedish twins. J Gerontol B Psychol Sci Soc Sci 56: 292-300. doi:10.1093/geronb/56.5.P292.
19. Lautenschlager NT, Cupples LA, Rao VS, Auerbach SA, Becker R, et al. (1996) Risk of dementia among relatives of Alzheimer's disease patients in the MIRAGE study: What is in store for the oldest old? Neurology 46: 641-650. doi:10.1212/WNL.46.3.641. PubMed: 8618660.
20. Kivipelto M, Helkala EL, Laakso MP, Hänninen T, Hallikainen M, et al. (2001) Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ 322: 1447-1451. doi:10.1136/bmj.322.7300.1447. PubMed: 11408299.
21. Norton MC, Smith KR, Østbye T, Tschanz JT, Schwartz S, et al. (2011) Early parental death and remarriage of widowed parents as risk factors for Alzheimer disease: the Cache County study. Am J Geriatr Psychiatry 19: 814-824. doi:10.1097/JGP.0b013e3182011b38. PubMed: 21873837.
22. Farrer LA, O'Sullivan DM, Cupples LA, Growdon JH, Myers RH, (1989) Assessment of genetic risk for Alzheimer's disease among first-degree relatives. Ann Neurol 25: 485-493. doi:10.1002/ana.410250511. PubMed: 2774490.
23. Albright F, Teerlink C, Werner TL, Cannon-Albright LA, (2012) Significant evidence for a heritable contribution to cancer predisposition: a review of cancer familiality by site. BMC Cancer 12: 138. doi:10.1186/1471-2407-12-138. PubMed: 22471249.
24. Albright FS, Orlando P, Pavia AT, Jackson GG, Cannon Albright LA, (2008) Evidence for a heritable predisposition to death due to influenza. J Infect Dis 197: 18-24. doi:10.1086/524064. PubMed: 18171280.
25. Patel AA, Spiker WR, Daubs M, Brodke D, Cannon-Albright LA, (2011) Evidence for an inherited predisposition to lumbar disc disease. J Bone Joint Surg Am 93: 225-229. doi:10.2106/JBJS.J.00276. PubMed: 21266637.
26. Shirts BH, Burt RW, Mulvihill SJ, Cannon-Albright LA, (2010) A population-based description of familial clustering of pancreatic cancer. Clin Gastroenterol Hepatol 8: 812-816. doi:10.1016/j.cgh.2010.05.012. PubMed: 20570637.
27. Tashjian RZ, Farnham JM, Albright FS, Teerlink CC, Cannon-Albright LA, (2009) Evidence for an inherited predisposition contributing to the risk for rotator cuff disease. J Bone Joint Surg Am 91: 1136-1142. doi:10.2106/JBJS.H.00831. PubMed: 19411462.
28. Teerlink CC, Hegewald MJ, Cannon-Albright LA, (2007) A genealogical assessment of heritable predisposition to asthma mortality. Am J Respir Crit Care Med 176: 865-870. doi:10.1164/rccm.200703-448OC. PubMed: 17690335.
29. Kamb A, Shattuck-Eidens D, Eeles R, Liu Q, Gruis NA, et al. (1994) Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat Genet 8: 23-26. PubMed: 7987388.
30. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, et al. (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66-71. doi:10.1126/science.7545954. PubMed: 7545954.
31. Tavtigian SV, Simard J, Teng DH, Abtin V, Baumgard M, et al. (2001) A candidate prostate cancer susceptibility gene at chromosome 17p. Nat Genet 27: 172-180. doi:10.1038/84808. PubMed: 11175785.
32. Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, et al. (1994) Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265: 2088-2090. doi:10.1126/science.8091231. PubMed: 8091231.
33. Cameron HM, McGoogan E, (1981) A prospective study of 1152 hospital autopsies: I. Inaccuracies in death certification. J Pathol 133: 273-283. doi:10.1002/path.1711330402. PubMed: 7241267.
34. Dollear W, Gorelick PB, Harris Y, Miles T, Bozzola F, (1992) Vascular dementia: a clinical and death certificate study. Neuroepidemiology 11: 53-58. doi:10.1159/000110912. PubMed: 1495574.
35. Frecker MF, Pryse-Phillips WE, Strong HR, (1995) Alzheimer's disease death certificates. Neurology 45: 2298-2299. doi:10.1212/WNL.45.12.2298. PubMed: 8848217.
36. Ganguli M, Rodriguez EG, (1999) Reporting of dementia on death certificates: a community study. J Am Geriatr Soc 47: 842-849. PubMed: 10404929.
37. Newens AJ, Forster DP, Kay DW, (1993) Death certification after a diagnosis of presenile dementia. J Epidemiol Community Health 47: 293-297. doi:10.1136/jech.47.4.293. PubMed: 8228765.
38. Raiford K, Anton-Johnson S, Haycox Z, Nolan K, Schaffer A, et al. (1994) CERAD partVII: accuracy of reporting dementia on death certificates of patients with Alzheimer's disease. Neurology 44: 2208-2209. doi:10.1212/WNL.44.11.2208.
39. Ostbye T, Taylor DH Jr, Clipp EC, Scoyoc LV, Plassman BL, (2008) Identification of dementia: agreement among national survey data, medicare claims, and death certificates. Health Serv Res 43: 313-326. PubMed: 18211532.
40. Tschanz JT, Corcoran C, Skoog I, Khachaturian AS, Herrick J, et al. (2004) Dementia: the leading predictor of death in a defined elderly population: the Cache County Study. Neurology 62: 1156-1162. doi:10.1212/01.WNL.0000118210.12660.C2. PubMed: 15079016.
41. Gill TM, Gahbauer EA, Han L, Allore HG, (2010) Trajectories of disability in the last year of life. N Engl J Med 362: 1173-1180. doi:10.1056/NEJMoa0909087. PubMed: 20357280.
42. Hoyert DL, (1996) Mortality trends for Alzheimer's disease, 1979-91. Vital Health Stat 20: 1-23. PubMed: 9373367.
43. Martyn CN, Pippard EC, (1988) Usefulness of mortality data in determining the geography and time trends of dementia. J Epidemiol Community Health 42: 134-137. doi:10.1136/jech.42.2.134. PubMed: 3146614.
44. Mitchell SL, Teno JM, Miller SC, Mor V, (2005) A national study of the location of death for older persons with dementia. J Am Geriatr Soc 53: 299-305. doi:10.1111/j.1532-5415.2005.53494.x. PubMed: 15673356.
45. Malecot, (1948) Les mathematiques de l'heredite. Paris: Masson.
46. Agresti, (1990) Categorical Data Analysis. New York: Wiley.
47. McLellan T, Jorde LB, Skolnick MH, (1984) Genetic distances between the Utah Mormons and related populations. Am J Hum Genet 36: 836-857. PubMed: 6591796.
48. Jorde LB, (1989) Inbreeding in the Utah Mormons: an evaluation of estimates based on pedigrees, isonymy, and migration matrices. Ann Hum Genet 53: 339-355. doi:10.1111/j.1469-1809.1989.tb01803.x. PubMed: 2624429.
49. Farrer LA, Cupples LA, van Duijn CM, Kurz A, Zimmer R, et al. (1995) Apolipoprotein E genotype in patients with Alzheimer's disease: implications for the risk of dementia among relatives. Ann Neurol 38: 797-808. doi:10.1002/ana.410380515. PubMed: 7486872.